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ABSTRACT The inﬂuence of cholesterol and POPE on lung surfactant model systems consisting of DPPC/DPPG (80:20) and
DPPC/DPPG/surfactant protein C (80:20:0.4) has been investigated. Cholesterol leads to a condensation of the monolayers,
whereas the isotherms of model lung surfactant ﬁlms containing POPE exhibit a slight expansion combined with an increased
compressibility at medium surface pressure (10–30 mN/m). An increasing amount of liquid-expanded domains can be
visualized by means of ﬂuorescence light microscopy in lung surfactant monolayers after addition of either cholesterol or POPE.
At surface pressures of 50 mN/m, protrusions are formed which differ in size and shape as a function of the content of
cholesterol or POPE, but only if SP-C is present. Low amounts of cholesterol (10 mol %) lead to an increasing number of
protrusions, which also grow in size. This is interpreted as a stabilizing effect of cholesterol on bilayers formed underneath the
monolayer. Extreme amounts of cholesterol (30 mol %), however, cause an increased monolayer rigidity, thus preventing
reversible multilayer formation. In contrast, POPE, as a nonbilayer lipid thought to stabilize the edges of protrusions, leads to
more narrow protrusions. The lateral extension of the protrusions is thereby more inﬂuenced than their height.
INTRODUCTION
The prerequisite for functional lung breathing is a reduced
surface tension inside the alveoli. A thin lung surfactant ﬁlm,
which in human covers nearly 100 m2 in size, is responsible
for a low surface tension at the air/water interface. Lung
surfactant consists of ;90% (w/w) lipids, mainly phospho-
lipids, and 10% proteins. Four speciﬁc surfactant proteins are
known, two hydrophilic (SP-A and SP-D) and two hydro-
phobic ones (SP-B and SP-C). Surface active components of
the LS are, however, mainly SP-B and SP-C. The importance
of the hydrophobic protein fraction has been demonstrated by
knockout mice. SP-B deﬁciency proved to be lethal for
animals (Akinbi et al., 1997), whereas results from SP-C
knockout animals show pulmonary disorder associated with
emphysema, monocytic inﬁltration, and epithelial cell dys-
plasia (Glasser et al., 2003). Congenital alveolar proteino-
sis with a hereditary SP-B deﬁciency results in a lack of
tubular myelin (Claypool, 1988) and an increased formation
of SP-C precursors (Nogee et al., 1993; Vorbroker et al.,
1995). Of the phospholipids within the LS, ;80% are
phosphatidylcholines, and ;50% of them contain the
saturated palmitoic acid chains (DPPC) (Kahn et al., 1995).
Pure DPPC ﬁlms can reach a surface tension near 0 mN/m
during compression, but ﬁlm formation is limited by a very
slow adsorption of lipids from the subphase to the air/water-
interface during expansion (Poulain and Clements, 1995;
Robertson and Halliday, 1998; Veldhuizen and Haagsman,
2000).
It is presumed that the surface ﬁlm within the alveolus
is enriched with DPPC by selective adsorption from the
subphase and/or a ‘‘squeeze out’’ of non-DPPC phospholip-
ids during the breathing cycle (Goerke and Clements, 1986;
Keough, 1992; Pison et al., 1996). Probably the components
of surfactant ﬁlmsmust collapse collectively rather than being
squeezed out individually (Schief et al., 2003).
Although the natural LS ﬁlm consists of more than one
monolayer (Schu¨rch et al., 1995), it is not clear which com-
ponents of this ﬁlm are involved in multilayer formation and
the sustainment of such a ﬁlm in vitro.
A number of phospholipids are found in very low concen-
trations in native surfactants (Veldhuizen et al., 1998). These
minor lipid components, like lyso-phosphatidylcholine,
phosphatidylserine, phosphatidylethanolamine, or lyso-bis-
phosphatidic-acid, have characteristic asymmetric structures.
Partially unsaturated POPE, however, is able to form bilayers
above the collapse pressure (Saulnier et al., 1999) and en-
hances the lateral mobility in various phosphatidylcholine
lipid bilayers (Ahn and Yun, 1999).
The inclusion of these minor lipid components into the
investigations of surfactant properties may lead to a better
understanding of the mechanism, by which this complex
biological surface active material interacts at the air/water
interface. An important question is what correlations exist
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between the properties of asymmetric phospholipids and the
properties of a mixture of the LS containing these lipids.
Therefore, we have chosen POPE in different concentrations
(0, 1, 10, and 30 mol %) as an example of asymmetric
phospholipids and investigated their inﬂuence of the surface
behavior on the LS model system consisting DPPC/DPPG/
SP-C (80:20:0.4).
In mammalian species, cholesterol appears to be the major
neutral lipid component (80–90%). The extracellular surfac-
tant contains 3–10% cholesterol with respect to the total
phospholipid (Veldhuizen and Haagsman, 2000). Due to its
molecular structure cholesterol contributes to different func-
tions such as stabilizing and ﬂuidizing lipid mono- and
bilayers (Smaby et al., 1997;Vist andDavis, 1990). Cholesterol
can enhance adsorption of vesicles that are primarily com-
posed of DPPC, presumably by increasing the ﬂuidity of the
condensed monolayer, thus improving ﬁlm respreading
(Fleming and Keough, 1988; Notter et al., 1980). However,
it should be noted that cholesterol limits the minimum surface
tension of the surface ﬁlm as a result of an inhibited ‘‘squeeze
out’’ of the sterol from DPPC/cholesterol monolayers (Notter
et al., 1980; Yu and Possmayer, 1996; Yu and Possmayer,
1998). In binary monolayers with phosphatidylcholine,
cholesterol changes the viscosity of monolayers (Tanaka
et al., 1999) and inﬂuences protein adsorption due to strong
interactions between phosphatidylcholine headgroups (Kim
et al., 2001). The evolutionary analysis of surfactant composi-
tion revealed that ﬁsh lungs have;3-fold greater amounts of
cholesterol relative to phospholipids than other vertebrate
groups (Daniels and Orgeig, 2003). In addition to the large
evolutionary changes of the surfactant, temperature is also
an acute controller of the lipid composition. Temperature-
associated changes of cholesterol concentration in surfactant
have previously been demonstrated in the Central Australian
lizard,Ctenophorusmuchalis (Daniels et al., 1990). It appears
that at low body temperature the lungs of these animals
increase the level of cholesterol in their surfactant to maintain
the ﬂuidity.
Previous studies have shown that SP-B and SP-C are
involved in the formation of surface-associated reservoirs of
lipid/proteinmultilayers (Krol et al., 2000; vonNahmen et al.,
1997; Burns, 2003). Wilhelmy ﬁlm balance, FLM, and SFM
studies lead to a possible scenario of inﬂuences of SP-B and
SP-C on the morphology of phospholipid monolayers: SP-B-
containing ﬁlms form disc-like protrusionswith a thickness of
one bilayer, whereas SP-C tends to form extended plateaus
consisting of stacked bilayers. These stacked bilayers, which
are found in the plateau region of the isotherms, are composed
of phospholipids and SP-C (Bourdos et al., 2000), and show
a layer thickness of 5.5–6.5 nm (Amrein et al., 1997; Galla
et al., 1998; Krol et al., 2000; von Nahmen et al., 1997).
In this work, we focus on the inﬂuence of the components
cholesterol and POPE on the morphology of mixed mono-
layers at different surface pressures in comparison to the LS
model system. Upon compression cholesterol- and POPE-
containing monolayers provide a range of structural changes
that are visualized by means of SFM.
MATERIALS AND METHODS
Materials
SP-C was isolated from porcine lungs by the method described by
Haagsman et al., 1987. DPPC, DPPG, and POPE were purchased from
Avanti Polar Lipids (Alabaster, AL). BODIPY-PC was obtained from
Molecular Probes (Eugene, OR) and cholesterol (.99% purity) from Sigma
Aldrich Chemie (Steinheim, Germany). All lipids were used without further
puriﬁcation. Solvents were purchased from Merck (Darmstadt, Germany)
and were of high-performance liquid chromatography grade.
Film balance measurements
Measurements were performed on a Wilhelmy ﬁlm balance (built by Riegler
and Kirstein, Mainz, Germany) with an operational area of 144 cm2 on pure
water (MilliQ quality, Milli-Q185Plus; Millipore, Eschborn, Germany). All
measurement were performed at a temperature of 20C. Monolayers
composed of DPPC/DPPG in a molar ratio of 4:1 were supplemented with
0.4 mol % SP-C as denoted. Different amounts of cholesterol or POPE were
added as indicated. The lipid/proteinmixtureswere spread from a chloroform/
methanol solution (1:1) onto the aqueous subphase. After an equilibrium time
of 10 min, the monolayers were compressed at a rate of 5.81 cm2/min.
Fluorescence light microscopy
Domain structures of lipid mixtures were visualized by means of a
ﬂuorescence light microscope (Olympus BX-FLA light microscope, equip-
ped with an xy-stage; Olympus, Hamburg, Germany). All lipid and lipid/
protein compositions were doped with 0.4 mol % BODIPY-PC.
Langmuir-Blodgett transfer
LB ﬁlms were prepared by spreading a lipid/protein mixture dissolved in
chloroform/methanol (1:1) onto a pure water subphase of a Wilhelmy ﬁlm
balance with an operational area of 39 cm2. Before spreading, a mica sheet
(Electron Microscopy Science, Munich, Germany) was dipped into the
subphase. After an equilibration period of 10 min, the ﬁlm was compressed
with a velocity of 1.79 cm2/min until the plateau region of the isotherms was
reached (nearly 50mN/m) and transferred onto themica sheet (0.64mm/min)
under constant surface pressure. This was guaranteed by regulating the speed
of the barrier manually. By using FLM, time-of-ﬂight secondary ion mass
spectrometry,, and Brewster angle microscopy it was shown that structures
transferred from the air-water interface onto solid substrates are essentially
identical (Galla et al., 1998; Lee et al., 1998; Leufgen et al., 1996).
Scanning force microscopy
Surface images of the LB ﬁlms were obtained at ambient conditions using
a Nanoscope IIIa Dimension 3000 microscope from Digital Instruments
(Santa Barbara, CA) operating in tapping mode. Silicon tips (BS-Tap 300,
Nanoscience Instruments, Phoenix, AZ) with a resonance frequency of 250–
300 kHz were used.
Statistical analysis
FLM images were converted to 2563 255 pixels and a resolution of 2543
254 DPI, and decreased to a color depth of 8 BPP. Care was taken to keep
a constant gain during the experiments. Owing to the inhomogeneous
illumination of the monolayer by the light source, the intensities of the pixels
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Ixy,raw of the images were corrected. This was done by ﬁtting a paraboloid to
the image data and subtracting the paraboloid from the data. The corrected
values of the intensities of the pixel Ixy at the locations (x, y) are given by
Ixy ¼ Ixy;raw Mxðx  x0Þ2 Myðy y0Þ2; (1)
where Ixy,raw are the raw values, andMx, My, x0, and y0 are ﬁtted parameters
characterizing the inhomogeneous illumination of the monolayer.
To calculate the areas Ad and Ab of the surface covered by the domains,
the method described by von Nahmen and co-workers (1997) was used. The
area of dark (d ) and bright domains (b), and the mean ﬂuorescence
intensities Id and Ib obtained from histograms of the ﬂuorescence intensities
were analyzed from digital images. The histograms could be ﬁtted in most
cases by a sum of two Gaussian functions (see Fig. 5 a). Each of the
Gaussian funtions represents the intensity distribution of the dark Nd(I) or
bright domain Nb(I). The parameters Ad, Ab, Id; and Ib were calculated from
the integral and the means of the Gaussian distributions.
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N(I) is the number of pixels with the intensity I, Nt the total number of pixels,
Ad*¼ Ad/(Ad1 Ab) and Ab*¼ Ab/(Ad1 Ab) are the relative areas (0, A*, 1)
of the dark and bright domains, and Id and Ib are the corresponding mean
intensities. The parameters sd and sb represent the width of the distri-
butions.
SFM images were also converted to 2563 255 pixels with a resolution of
254 3 254 DPI and decreased to a color depth of 8 BPP. Additionally, the
SFM images were converted to a gray scale. To determine the parameters
Ad*, Ab*, Id; and Ib; which describe in the SFM images, the dark (d) area of the
monolayer, the bright (b) area of the protrusions, and the mean height
intensity of the protrusions (Ib) and the monolayer Id; the histograms were
analyzed as follows: up to a certain intensity Ilimit the histograms were ﬁtted
by one Gaussian function yielding the parameters Id and Ad* (and Ab* ¼ 1 
Ad*). The Gaussian function was then subtracted from the histogram,
resulting in the intensity distribution of the bright domain Nb. Without
knowledge of the concrete distribution function, an evaluation of the
parameter Ib is then possible according to
Ib ¼
+
I. Ilimit
NbI
+
I. Ilimit
Nb
; (3)
with Nb representing the number of pixels of the bright domains with the
height intensity I. The applicability of the procedure was checked by
changing the value of limit in a narrow range. No signiﬁcant changes in the
desired parameters were obtained.
For calculation of protrusion sizes shown with SFM, all adjacent pixels
with similar color were ﬁgured up, whereas differences in gray scale not
larger than 50 were accounted. That way, domain sizes, which are composed
of many shades of single colors, have been determined.
RESULTS
Inﬂuence of cholesterol on model
surfactant systems
Cholesterol leads to a shift of model surfactant isotherms to
lower molecular areas as a result of an incorporation of
cholesterol between the alkyl chains of the phospholipids
(Fig. 1). The transition of lipids from the liquid-expanded (le)
to the liquid-condensed (lc) phase appears at a surface
pressure of ;5 mN/m. SP-C-containing surfactant systems
have a second plateau at a surface pressure of;50mN/m (Fig.
1 b), which is attributed to the collapse surface pressure of
SP-C-containing monolayers. In contrast to the SP-C-free
monolayers, the plateau of the lipid phase transition vanishes
by increasing the amount of cholesterol. The SP-C-induced
plateau at 50 mN/m, however, remains unaffected by the
addition of cholesterol. Due to the incorporation of choles-
terol, the monolayer stiffens in a more condensed manner
compared to the cholesterol-free system.
In the ﬂuorescence images of DPPC/DPPG (80:20)
monolayers, dark kidney-shaped domains are visible, which
form coherent lc areas at high surface pressures (Fig. 2, a, e,
and i). Addition of cholesterol leads to the formation of small
circular structures and to a decrease of the total lc area (Fig. 2,
b–d) at low surface pressure. In the case of low concentrations
of cholesterol (1% and 10%, Fig. 2, f, g, j, and k), fractal
structures are observed during compression, whereas the
number of circular domains remains unaffected in the case of
high concentrations of cholesterol (30%) (Fig. 2, h and l). The
lc domains increase only in size but not in number. Choles-
terol, which is known to disturb preferentially the tightly
packed domains at high surface pressure, obviously causes an
increase of the solubility of the ﬂuorescence dye (Fig. 2, i–l).
FIGURE 1 Compression isotherms of DPPC/DPPG (80:20) (a) and
DPPC/DPPG/SP-C (80:20:0.4) (b) monolayers containing an increasing
amount of cholesterol (shaded arrow). The concentrations of cholesterol are
0, 1, 5, 10, and 30 mol % of the total lipid amount. FLM images were taken
at the surface pressures marked by black arrows.
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FLM images of the model system DPPC/DPPG/SP-C
(80:20:0.4) are similar to the protein-free system but exhibit
some differences. Circular domains cover nearly the complete
surface of all monolayers. At 5 mN/m and with increasing
amounts of cholesterol the total area of the lc phase decreases
with respect to the le phase (Fig. 2, m–p). At higher surface
pressures (30 and 50 mN/m) the le phase vanishes and the
monolayers with lesser amounts of cholesterol are nearly in
the condensed phase (Fig. 2, q, r, u, and v). A molar ratio of
10% cholesterol causes the formation of small circular do-
mains that aggregate with long-range order (Fig. 2, s and w).
At the highest content of cholesterol (30 mol %), the
perturbation of the close-packed domains leads to an equal
distribution of the ﬂuorescence intensity that appears as
a homogeneous phase (Fig. 2, t and x).
Inﬂuence of POPE on model surfactant systems
The isotherms of DPPC/DPPG (80:20) and DPPC/DPPG/
SP-C (80:20:0.4) show an increasing compressibility during
FIGURE 2 Fluorescence light micros-
copy images of DPPC/DPPG (80:20) (a–i)
and of DPPC/DPPG/SP-C (80:20:0.4) (m–
x) monolayers containing different amounts
of cholesterol. Images were taken at surface
pressures marked in Fig. 1. The concen-
trations of cholesterol are: 0 mol % (ﬁrst
row), 1 mol % (second row), 10 mol %
(third row), and 30 mol % (fourth row). The
image size is 130 3 130 mm2.
Role of Cholesterol/POPE on Surfactant 2641
Biophysical Journal 88(4) 2638–2649
compression between 10 and 20mN/m at a constant area with
increasing amounts of POPE (Fig. 3 a). The lipid phase
transition from the le to the lc phase is observed as a plateau at
;5 mN/m, which diminishes with an increasing amount of
POPE. SP-C leads to the formation of a second plateau at
50 mN/m (Fig. 3 b). Due to the ﬂuidizing effect of the unsatu-
rated alkyl chain of POPE the lipid phase transition broadens
and ﬁnally vanishes; this process is accompanied by a higher
monolayer compressibility between 10 and 30 mN/m.
Addition of POPE to model surfactant systems leads to
a ﬂuidization of the monolayers visible by a quantitative
reduction of lc domains (Fig. 4, a–c) and a decrease in their
size. Correspondingly, the area occupied by the le phase
increases, leading to a higher compressibility of the mono-
layers. During compression, lc domains grow in size and are
either of circular or kidney-like shape (Fig. 4, d–i). At high
surface pressures and at a low concentration of POPE (1 mol
%), a network of lc domains occurs, which is disrupted
through further addition of POPE (Fig. 4, g–i). In general, the
unsaturated alkyl chain of POPEpromotes an incorporation of
the ﬂuorescence dye to give a bright domain surrounding
single circular lc domains.
SP-C leads to the formation of very small circular lc
domains, which partly aggregate (Fig. 4, j–l). At high surface
pressures the contrast between dark lc domains and bright le
domains diminishes (Fig. 4, m–r). Nevertheless, a ﬁrm phase
interface of the domains remains and lc domains obviously
consist of saturated lipids surrounded by POPE molecules.
Accordingly, POPE molecules should stabilize the borders
of lc domains and the increasing le arrays are predominantly
composed of POPE.
FIGURE 3 Compression isotherms of (a) DPPC/DPPG (80:20) and (b)
DPPC/DPPG/SP-C (80:20:0.4) monolayers containing an increasing amount
of POPE (shaded arrow). The concentrations of POPE are 0, 1, 5, 10, and
30 mol % of the total lipid amount. FLM images were taken at the surface
pressures marked by black arrows.
FIGURE 4 Fluorescence light microscopy images of DPPC/DPPG
(80:20) (a–i) and of DPPC/DPPG/SP-C (80:20:0.4) (m–x) monolayers
containing different amounts of POPE. Images were taken at surface
pressures marked in Fig. 2. The concentrations of POPE are: 0 mol % (ﬁrst
row), 1 mol % (second row), 10 mol % (third row), and 30 mol % (fourth
row). The image size is 130 3 130 mm2.
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Quantiﬁcation of the inﬂuence of minor
components on the phase behavior of
model surfactant monolayers
The visual impression of FLM images was quantiﬁed by
a statistical analysis. At a surface pressure of 5 mN/m the
different surfactant model systems with various amounts of
cholesterol or POPE were analyzed to quantitate the area
occupied by the le and the lc phases, respectively. Histograms
of the FLM images indicate a normal distribution around
a bright and a dark gray-scale value (Fig. 5 a). The solid lines
represent the ﬁtting of data as the sum of two Gaussian
distributions (Eq. 2). The point of intersection of both normal
distributions corresponds to the border between bright and
dark phases, and the areas of the two phases were calculated
by an integration of Gaussian distributions. Both minor
components, cholesterol and POPE, lead to an increase of the
ratio of bright and dark domains Ab*/Ad* (Fig. 5, b and c). The
inﬂuence of cholesterol/POPE on the protein-free system
DPPC/DPPG (80:20) is higher than the inﬂuence on DPPC/
DPPG/SP-C (80:20:0.4). Cholesterol has a stronger inﬂuence
on the protein-free surfactant system than POPE, but the
addition of 0.4% SP-C leads to a drastic change. Addition of
POPE to DPPC/DPPG/SP-C (80:20:0.4) monolayers ampli-
ﬁes the area of bright domains in comparison to cholesterol-
containing membranes. Due to the unsaturated fatty acid,
POPE is assumed to be responsible for the ﬂuidization of the
model lung surfactant monolayers, whereas cholesterol leads
to the formation of a lower amount of lc phase by an incor-
poration and disturbance of lc phase.
Topographical and height analysis
To consider the proposed three-dimensionalmodel of the lung
surfactant, the lipid/protein mixtures were transferred at a
surface pressure of 47 mN/m by using a LB transfer to mica
sheets and were examined by means of SFM (Galla et al.,
1998). The model system DPPC/DPPG/SP-C (80:20:0.4)
forms long ﬁlamentous protrusions (Fig. 6 a) in a long-range
order (Fig. 7 a). A height analysis of these protrusions
visualizes the formation of lipid bilayers up to a quadruple
bilayer assuming a lipid bilayer thickness of;6 nm (Table 1).
SFM images of DPPC/DPPG/SP-C (80:20:0.4) with an
additional amount of either 10% (Fig. 6 b) or 30% cholesterol
(Fig. 6 c) reveal the formation of two types of distinct pro-
trusions. With less amount of cholesterol numerous broad
protrusions are formed, which supports the hypothesis that
cholesterol stabilizes lipid double layers (Table 1). The
protrusions exhibit one lipid bilayer. Partly, these protrusions
consist of a protrusion of higher order leading to the formation
of a second bilayer sitting on top of the ﬁrst bilayer.With high
amounts of cholesterol, most of the protrusions vanish; only
isolated ones appear. These protrusions consist of a punctual
structure with a maximum height of two bilayers. Further-
more, several protrusions appear, which are comparable with
the structures existing at 10 mol %. In general, 30 mol %
cholesterol inhibits multilayer formation. Therefore, the
addition of cholesterol reduces the total number of stacks
within the protrusions in comparison to the model system
DPPC/DPPG/SP-C (80:20:0.4) (Table 1).
POPE induces the formation of small circular protrusions
(Fig. 6 d) that decrease in size but increase in number upon
further addition of POPE (Fig. 6 e, Table 1). The long-range
order is characterized by long ﬁlaments that consist of many
small protrusions interrupted by ﬂat areas (Fig. 7 c). High
amounts of POPE (30%) lead to the formation of separated
FIGURE 5 Statistical analysis of FLM images at a surface pressure of
5 mN/m. (a) The areas of bright and dark domains were calculated by ﬁtting
the data to the sum of two Gaussian distributions. The Gaussian curve with
an area of 78% represents the le phase, whereas the other one marks the dark
domains with a total area of 22%. (b and c) Histograms of ﬂuorescence light
intensity of (b) DPPC/DPPG (80:20) and (c) DPPC/DPPG/SP-C (80:20:0.4)
monolayers with various amounts of cholesterol/POPE. Model surfactant
system in black, cholesterol-doped in light shaded, and POPE-doped in dark
shaded.
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FIGURE 6 SFM images and height proﬁles of DPPC/DPPG/SP-C ﬁlms containing different amounts of cholesterol/POPE. (a) 0 mol % of cholesterol/
POPE, (b) 10 mol % of cholesterol, (c) 30 mol % of cholesterol, (d) 10 mol % of POPE, and (e) 30 mol % of POPE. The line scans exhibit the height proﬁle.
Protrusions are visualized as single steps of lipid bilayers. The image size is 5 3 5 mm2.
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protrusions, whereas their total area remains constant (Table
1). We conclude that this effect corresponds to an increasing
relative surface of the edge of protrusions, which shows the
rim-stabilizing effect of the nonbilayer lipid POPE.
DISCUSSION
This study focuses on the inﬂuence of cholesterol and POPE
on a pure lipid, DPPC/DPPG (80:20), and on a lung surfactant
model system, DPPC/DPPG/SP-C (80:20:0.4). The investi-
gation contributes to a further understanding of the function of
these so-called minor components in the alveolus during the
breathing cycle.
Bilayer stabilizing effect of cholesterol
Film balance experiments indicate that cholesterol is in-
corporated between the alkyl chains of phospholipids,
resulting in less required space compared to the expected
space of alkyl chains as a sum of the pure components. This
has also been reported by Kim et al. (2001) for cholesterol-
doped DPPC and DPPG monolayers. The hydroxylic group
of cholesterol interacts with the headgroups of DPPC and
DPPG (Mozaffary, 1994), DLPC (Tanaka et al., 1999), and
protein-containing monolayers such as DPPC/GM1 (Yuan
and Johnston, 2000). The condensing effect of cholesterol
leads to an ordered monolayer at concentrations .30 mol %
cholesterol (Kim et al., 2001). Isotherms of mixed lipid/
FIGURE 7 SFM images and histo-
grams of the gray-scale analysis of
model surfactant monolayers. (a) DPPC/
DPPG/SP-C (80:20:0.4), (b) DPPC/
DPPG/SP-C/ cholesterol (80:20:0.4:
30), and (c) DPPC/DPPG/SP-C/POPE
(80:20:0.4:30). The insets show magniﬁ-
cations of the protrusions with an image
size of 2 3 2 mm2. The histogram
analysis of the full-scale images represent
ﬁts to a Gaussian distribution. The
image size is 25 3 25 mm2. Insets are
23 2 mm2.
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cholesterol monolayers show a great analogy to those of pure
cholesterol. At higher concentrations of cholesterol no uni-
form mixture is observed. An increase in rigidity resulting
from the condensing effect of cholesterol was shown by
plotting the area permolecule versus the cholesterol content at
constant pressure (Tanaka et al., 1999). The observed values
are below the calculated ones for an ideal mixture; thus, the
density of mixed lipid/cholesterol monolayers is higher than
the sum of the densities of the individual components.
Small amounts of surface active proteins should lead to
only minimal changes (Yuan and Johnston, 2000). At low
surface pressure the isotherms of DPPC/DPPG/SP-C (80:20:
0.4) show a phase behavior similar to the pure lipid mono-
layer, exhibiting the shift to smaller molecular areas with
rising concentration of cholesterol. At higher surface
pressures,;50 mN/m, SP-C leads to the reversible formation
of a plateau (von Nahmen et al., 1997), which is not affected
by cholesterol. At high concentrations of cholesterol, repeated
compression and expansion cycles do not lead to a signiﬁcant
loss of material. By increasing the amount of cholesterol only
the phase transition between le and lc vanishes, indicating a
disturbing effect of cholesterol within lc domains due to its
incorporation between the alkyl chains of the phospholipids.
The orientation of these alkyl chains within different phases is
hindered by cholesterol.
At low surface pressures, ﬂuorescence images of DPPC/
DPPG monolayers are characterized by kidney-shaped lc
domains within the le phase. Further compression leads to
higher amounts of lc domains and a decreased area of the le
phase. Fluorescence images of DPPC/DPPG monolayers
containing higher amounts of cholesterol exhibit a lower area
of lc phase, which was also reported by Worthman et al.
(1997). A cholesterol-rich phase segregates ordered domains
that exclude the ﬂuorescence dye. At high surface pressures,
the disaturated phospholipids form condensed domains that
are depleted of the ﬂuorescence dye. Cholesterol compensates
this condensing effect of phospholipids under surface pres-
sure, leading to a decreased area of lc phase wherein the
ﬂuorescence dye is not soluble. Tanaka et al. (1999) made
similar observations while investigating DLPC/cholesterol
mixtures. Cholesterol induces a superstructure, preventing
domain formation (Somerharju et al., 1985; Virtanen et al.,
1995). This model is based on the assumption that each
cholesterol molecule replaces a single acyl chain of phos-
pholipids in their hexagonal lattice, and cholesterol perturbs
this lattice due to its larger size. This perturbation is mini-
mized by a maximal separation of cholesterol molecules,
which can only be achieved by a hexagonal or centered
rectangular superlattice of cholesterol molecules.
Fluorescence images of cholesterol-containing DPPC/
DPPG/SP-C (80:20:0.4) monolayers reveal substantially
smaller circular lc domains compared to those of DPPC/
DPPG (80:20). These domains form anearly uniform lc area in
the plateau region, interrupted by small le arrays. These le
arrays consist of less-ordered alkyl chains in which the
ﬂuorescence dye is incorporated (Lo¨sche and Mo¨hwald,
1984; Nag et al., 1990; Helm and Mo¨hwald, 1988). Within
these le arrays protrusions are present, and their formation is
supported by SP-C (von Nahmen et al., 1997). SP-C reduces
the size of individual lc domains at a constant total area of lc
phase. This leads to an increase of the total length of the
interface between the le and lc phases. The protrusions consist
of stacked bilayers, each with a thickness of 6 nm. They
appear as single steps in the height proﬁle of SFM images
(Fig. 6). A long-range order of protrusions is characterized by
long, bright arrays of protrusions with varying size and height
enclosing ﬂat and round structures. These round structures
represent the lc phase consisting primarily of condensed
DPPC (Bourdos et al., 2000). In the presence of cholesterol,
protrusions cover a larger area of the surface, indicating
a positive effect of cholesterol on the formation of lipid
bilayers. Incorporation of cholesterol leads to a minimization
of the length of the phase interface between the le and lc
phases. This can be attributed to the line-active properties of
cholesterol (Sparr et al., 1999).
Since SP-C is responsible for multilayer formation, and
since the protrusions are uniformly distributed over the whole
surface, we guess that the protein is also homogeneously
distributed. For this reason the ﬁlamentous structures of the
cholesterol-free model system disappear.
Taneva and Keough describe similar observations while
investigating DPPC/SP-C/cholesterol mixtures. Cholesterol
prevents SP-C from self-aggregating and leads to a better
miscibility in the monolayer (Taneva and Keough, 1997).
These homogeneously dispersed protrusions were also found
by Diemel et al., who investigated DPPC/POPC/POPG/SP-C
monolayers in the presence of up to 20 mol % cholesterol
(Diemel et al., 2002). The authors suggest that a homogenous
dispersion of surfactant lipids may facilitate lipid insertion
into the monolayer. By increasing the amount of cholesterol
up to 30mol% the total number of protrusions decreases (Fig.
6 c). Separated very small multilayers appear; only a few large
crescent-shaped bilayers are observed, which contain sev-
eral multilayers (see Fig. 7 b, inset). Cholesterol seems to
strengthen the interaction of SP-Cwith lipid and consequently
TABLE 1 Topographical and height analysis of SFM images
of surfactant model systems
Surfactant model system
Area of
protusions
(%)
Height steps
of protrusions (nm)*
DPPC/DPPG/SP-C (80:20:0.4) 20 6 (1), 12 (2), 18 (3), 24 (4)
DPPC/DPPG/SP-C/cholesterol
(80:20:0.4:10)
27 6 (1), 12 (2)
DPPC/DPPG/SP-C/cholesterol
(80:20:0.4:30)
5 6 (1), 12 (2)
DPPC/DPPG/SP-C/POPE
(80:20:0.4:10)
23 6 (1), 12 (2), 18 (3)
DPPC/DPPG/SP-C/POPE
(80:20:0.4:30)
23 6 (1), 12 (2), 18 (3)
*Data in parentheses represent the number of bilayers.
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almost inhibits the squeeze-out from the monolayer (Taneva
and Keough, 1997). Due to the tendency of cholesterol to
maximize the distance between two molecules, a hexagonal
symmetric cholesterol superlattice is formed (Virtanen et al.,
1995), and the overall rigidity of the monolayer caused by
cholesterol prevents the model surfactant ﬁlms from forming
multilayers. In cases where nearly every third molecule is
cholesterol, the formation of micelle-like structures at the rim
of the protrusions is considerably disturbed (Fig. 8). A
medium amount of cholesterol (10%) has a bilayer-stabilizing
effect that promotes protrusion formation, whereas a high
amount of cholesterol (30%) inhibits multilayer formation by
increasing the rigidity of the monolayer.
POPE promotes protrusion formation
POPE has a ﬂuidizing effect on model surfactant monolayers,
resulting in a higher lateral mobility (Ahn and Yun, 1999).
Successive replacement of POPC by POPE leads to an
increase of the lateral mobility within binary mixtures.
Investigations of Saulnier et al. (1999) have shown that not
only are the headgroups of lipids crucial for the ﬂuidity of
a monolayer, but also the character of the alkyl chains
(Saulnier et al. 1999). The saturated palmitoyl chains of the
DPPE lead to lesser ﬂuidity than the unsaturated oleoyl chains
of DOPE. A combination of unsaturated and saturated alkyl
chains, present in POPE, leads to the highest ﬂuidity. Binary
mixtures of DPPE and DOPE lead to an increased ﬂuidity
comparable to that of POPE. These investigations are in
excellent agreement with the results of our study of the model
systems DPPC/DPPG/POPE (80:20:x) and DPPC/DPPG/SP-
C/POPE (80:20:0.4:x) (x represents a concentration of the
minor component of 1, 5, 10, or 30 mol %),, supporting the
conclusion that POPE-containing monolayers are character-
ized by an increased compressibility and ﬂuidity. These
effects are observed as a decrease in number and a size re-
duction of lc domains in FLM experiments. Due to its un-
saturated fatty acid, POPE is not incorporated into the lc
domains; thus the lipid is enriched in the le phase. At lower
concentrations, we propose an accumulation of POPE at
the interface between le and lc phases, whereas at high con-
centrations, le arrays preferentially consist of POPE. The
unsaturated alkyl chain enables an incorporation of the ﬂuo-
rescence dye into POPE-rich phases and prevents a squeeze-
out of the ﬂuorescence dye at high surface pressures.
Therefore, POPE leads to a higher amount of le phase.
In the presence of SP-C, POPE also has a ﬂuidizing effect
on the surfactant model system DPPC/DPPG/SP-C/POPE
(80:20:0.4:x). SP-C induces the formation of protrusions and
is itself responsible for a higher ﬂuidity of the monolayer
(Amrein et al., 1997). These multilayers are composed of
folded lipid bilayers and protein molecules, enabling the
retention of the ﬂuorescence dye (von Nahmen et al., 1997).
The ﬁlamentous structure of the model system DPPC/DPPG/
SP-C (80:20:0.4) is identical to the POPE-containing
systems, but with higher amounts of POPE the protrusions
get smaller and the multilayer formation becomes rare. The
number of protrusions increases, however, whereas the area
covered by protrusions remains constant. We propose that
POPE stabilizes the rim of protrusions due to its overall
conical shape. In contrast, DPPC and DPPG are of
cylindrical shape and therefore not able to stabilize the
FIGURE 8 Proposed model of cho-
lesterol/POPE interactions with the
model surfactant system DPPC/DPPG/
SP-C (80:20:0.4). POPE is enriched in
the rims of the protrusions, whereas
cholesterol stabilizes the bilayers.
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rims of the protrusions. POPE seems to disperse large lc into
small lc domains embedded in the ﬂuid le phase.
The inﬂuence of POPE on the shape of protrusions is more
pronounced than on their height (Fig. 6 e). In general, this
inﬂuence on protrusion formation is attributed to two different
effects. The lateral distribution within surfactant monolayers
is changed in the way that the average size of SP-C-rich
domains decreases with incorporated POPE. Due to its
chemical, and thus topological, structure (conical shape),
POPE stabilizes the interface between the le and lc phases.
This leads to an increase of the ratio of circumference to area.
This effect is independent of the surface pressure. At high
surface pressures POPE stabilizes the rims of protrusions,
promoting a three-dimensional orientation of micelle-like
structures (Fig. 8). Upon decreasing the molecular area,
protrusions are formed underneath the monolayers (Plasencia
et al., 2004), in which, probably, the hydrophilic headgroups
of the ﬁrst double layer face the hydrophilic headgroups of
the next. The a-helix domain of SP-C should be incorporated
in one bilayer (Pastrana et al., 1991; Vandenbussche et al.,
1992), and the palmitoyl chains might stretch into the
neighboring bilayer. In this picture, the fatty acids act as an
anchor between adjacent bilayers, especially near the rims of
the protrusions. In contrast, cholesterol stabilizes bilayers to
give a ﬂat surface. These ﬁndings suggest that the components
cholesterol and POPE of the surfactant ﬁlm inﬂuence the
formation of the reversible multilayer structures and are
relevant to stabilization of the lung during the breathing cycle.
This work was supported by the Deutsche Forschungsgesellschaft under
grant Sonderforschungsbereich 424/B9.
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